Lupin has received a tentative nod from the Food and Drug Administration for Olopatadine hydrochloride ophthalmic solution, 0.7% (OTC), which is a generic of Alcon Laboratories' Pataday Once Daily Relief, 0.7% (OTC). This product will be manufactured at Lupin’s Pithampur facility in India.
Olopatadine hydrochloride ophthalmic solution, 0.7% is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.
[Read more: Lupin receives FDA nod for 3 generics]
Olopatadine hydrochloride ophthalmic solution (RLD Pataday) had a market value of roughly $22 million, per IQVIA April 2024 data.
[Read more: Lupin receives FDA nod for 3 generics]